This job has expired

You will need to login before you can apply for a job.

Manager Clinical Quality Assurance

Corcept Therapeutics
Menlo Park, CA
Start date
Sep 23, 2023

View more

Clinical, Clinical Research, Quality
Required Education
Bachelors Degree
Position Type
Full time
Biotech Bay

Job Details

At Corcept Therapeutics, we believe the potential impact of cortisol modulation on the future of health has long gone overlooked. That is why for twenty-five years we have pushed the boundaries of what is possible, driven by fiercely independent science, open collaboration and the curiosity to follow the data wherever it leads.

Our company is committed to building a culture that values diverse perspectives and the unique contributions of every employee. Our vibrant community is made up of over 300 people—medical practitioners, scientists, and industry professionals—all with the shared goal of advancing the science of cortisol modulation to treat serious disease.

Our work has uncovered over 1000 proprietary selective cortisol modulators, including our marketed product, Korlym® (mifepristone), the first treatment available for those living with Cushing’s syndrome, a life-threatening condition caused by excess cortisol activity. Today, we have a unique opportunity to revolutionize the treatment of severe endocrine, oncology, metabolism and neurology disorders and aim to deliver better outcomes for the people affected by them.

The Manager of Clinical Quality Assurance position is an exciting opportunity to build upon solid clinical research experience to become a key member of the Clinical Quality Assurance team. This role will perform day-to-day clinical quality operations and compliance activities to support the success of the clinical studies sponsored or supported by Corcept.


  • Lead/manage Good Clinical Practice (GCP) audits, including clinical investigative site audits, clinical vendor audits, clinical department internal audits, Trial Master File (TMF) audits, and applicable study document audits, including Clinical Study Reports (CSRs)
  • Serve as a QA representative and support clinical study teams to provide compliance advice
  • Participate in review and approval of clinical study documents and clinical SOPs / Guidance Documents
  • Manage study-specific Clinical Study Audit Plans (CSAP) compliance for the assigned program by using a risk-based approach for Corcept clinical studies
  • Review and approve investigational product (IP) temperature excursions to ensure release or rejection of IP on time
  • Lead continuous improvement of the Clinical Quality Management Systems (CQMS) and processes, including creation and revision of SOPs for GCP compliance and excellence
  • Manage and support inspection readiness activities for GCP
  • Support clinical inspections conducted by regulatory agencies, including sponsor inspections, clinical investigative site inspections, and contract research organization (CRO) inspections
  • Support GMP, GLP, and PV inspections
  • Lead clinical non-compliance event investigations and CAPA implementation
  • Perform quality metric analysis for clinical QA including study quality event trends from clinical process deviations / CAPAs to include a review of protocol deviations, safety, and other clinical data
  • Maintain a contemporary knowledge of agency and industry trends, standards, and methodologies as related to GCPs. Maintain the GCP regulatory surveillance program
  • Provide cross-training development opportunities to QA team members, and mentor/coach junior QA team members upon request or as an assigned supervisor

Preferred Education & Experience

  • BA/BS degree in a relevant field, or equivalent experience
  • 6+ years’ clinical research experience
  • Understanding of Quality Systems that support GCP quality activities
  • Experience with advanced Microsoft Office applications (Word, Excel, PowerPoint)
  • Experience developing GCP processes for the best industry practices and training

Some travel required for this role

Corcept has a dynamic and authentic culture where we remain true to our principles while embracing continued growth. Our work is marked by innovation, integrity, collaboration, and honest communication. We all have unique contributions to make, and our success is the sum of those contributions.

Our work is anchored in leading the discovery and development of drugs that modulate the effects of cortisol. Through our collaborations with researchers around the world, more than 30 studies are underway to investigate the potential benefits GR antagonists may have in the treatment of serious and life-threatening diseases.

The pay range that the Company reasonably expects to pay for this position is $144,800 - $170,300; the pay ultimately offered may vary based on legitimate considerations, including job-related knowledge, skills, experience, and education.  An annual cash bonus and equity grants may be provided as part of the overall compensation package, in addition to a full range of medical, financial, and/or other wellness benefits, dependent on the position offered. 

Applicants must be currently authorized to work in the United States on a full-time basis.

If you are based in California, we encourage you to read this important information for California residents linked here.

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

 Please visit our website at:

Corcept is an Equal Opportunity Employer


Corcept is leading the discovery and development of drugs that modulate the effects of cortisol.
Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases.  Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since being founded in 1998.
Corcept is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs related to excess cortisol activity.  To support this mission, Corcept collaborates with numerous basic scientists and clinical researchers to find better ways to improve patient lives.
Through our collaborations with researchers around the world, more than 30 studies are underway to investigate the potential benefits GR antagonists may have in the treatment of serious and life-threatening diseases driven by cortisol dysregulation.

Stock Symbol: CORT

Company info
149 Commonwealth Drive
Menlo Park

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert